ICU Medical, Inc.

ICU Medical, Inc.

ICUI

$166.02

Updated: 25/09/2026, 09:03:38

Market Cap
$4.15B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Stock valuation chart
One-year closing share-price history for ICUI
Company Profile

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.

USD
NASDAQ
CEO: Vivek Jain
Employees: 13,000
https://www.icumed.com
Asset Summaries
Latest generated summaries for ICUI

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for ICUI.
Share price
$166.02
Market cap
$4.15B
Exchange
NASDAQ
Currency
USD
CEO
Vivek Jain
Employees
13,000
IPO date
31/03/1992
Beta
0.755
Last dividend
$0.00
Day range
$163.08 – $167.67
52-week range
$112.50 – $192.85
1-day performance
1.65%
1-year performance
47.57%
Current drawdown (1Y)
-13.91%
CIK
0000883984
CUSIP
44930G107
ISIN
US44930G1076
Created
07/12/2025, 04:39:50
Last update
25/09/2026, 09:03:38

Track ICU Medical, Inc. with an AI analyst

See which prediction-market events move ICUI, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.